Impact of splenectomy on outcomes of hematopoietic stem cell transplantation in pediatric patients with transfusion‐dependent thalassemia
- 22 June 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (9) , e28483
Abstract
Background: The role of splenectomy prior to hematopoietic stem cell transplantation (HSCT) is controversial. Only few studies compared the outcomes of splenectomized and nonsplenectomized children with transfusion‐dependent thalassemia (TDT) undergoing allogeneic HSCTs.Methods: A retrospective analysis was undertaken on a transplantation cohort of TDT patients; August 1987‐December 2014 to compare transplant outcomes between splenectomized and nonsplenectomized groups.Results: Ninety‐six transplants in 86 TDT patients were analyzed. Sixteen patients were splenectomized before HSCTs. The splenectomized patients were significantly older (8.0 ± 1.9 vs 4.7 ± 0.6 years; P = 0.001), had larger livers and spleens (P = 0.001), and had a significantly shorter neutrophil engraftment time (absolute neutrophil count > 500/mm3; 15.0 ± 2.3 vs 19.2 ± 1.3 days; P = 0.004). Graft rejection occurred in 13.8% of the nonsplenectomized group, but not among the splenectomized patients. Though the splenectomized group's mortality rate was higher (25.0% vs 8.8%), this was not statistically significant (P = 0.491). The main causes of death in both groups were severe infections. The five‐year overall survival (OS) rate was better for the nonsplenectomized group (91.78% vs 75.00%; P = 0.06).Conclusions: Although splenectomies prior to HSCT for the TDT patients in our cohort were associated with faster neutrophil engraftments and lower rejection rates, they did not produce significantly better OS or affect the mortality. As the splenectomies did not provide any distinct advantages, this procedure should not be routinely performed as a pre‐HSCT regimen for TDT patients with splenomegaly. Better pre‐HSCT preparation for TDT patients, including early and adequate blood transfusions to avoid splenomegaly, is recommended.Keywords
This publication has 21 references indexed in Scilit:
- The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last DecadeTransplantation and Cellular Therapy, 2011
- HLA-matched sibling bone marrow transplantation for β-thalassemia majorBlood, 2011
- Impact of pretransplant splenectomy on patients with β‐thalassemia major undergoing a matched‐related allogeneic stem cell transplantationPediatric Transplantation, 2009
- Recognizing and Managing Chronic Graft-Versus-Host DiseaseHematology-American Society Hematology Education Program, 2008
- Hemostatic alterations in splenectomized and non-splenectomized patients with β-thalassemia/hemoglobin E diseaseThrombosis Research, 2007
- Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoringCancer Chemotherapy and Pharmacology, 2007
- Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemiaHeart, 2006
- Bone Marrow Transplantation in Patients with ThalassemiaNew England Journal of Medicine, 1990
- BENEFICIAL EFFECT OF PRE-TRANSPLANT SPLENECTOMY ON DISPLACEMENT BONE MARROW TRANSPLANTATION FOR GAUCHER'S SYNDROMEThe Lancet, 1987
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974